Tag Archives: non-small cell lung cancer

Liquid Biopsy: Differences Among Technologies


Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss differences among platforms for genetic profiling of metastatic non–small cell lung cancer in terms of sensitivity, specificity, and multiplex capability, as well as detection of complex genomic alterations.

Read More »